Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The deletion of AQP4 and TRPV4 affects astrocyte swelling/volume recovery in response to ischemia-mimicking pathologies

Z. Hermanova, L. Valihrach, J. Kriska, M. Maheta, J. Tureckova, M. Kubista, M. Anderova

. 2024 ; 18 (-) : 1393751. [pub] 20240515

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24012763

INTRODUCTION: Astrocytic Transient receptor potential vanilloid 4 (TRPV4) channels, together with Aquaporin 4 (AQP4), are suspected to be the key players in cellular volume regulation, and therefore may affect the development and severity of cerebral edema during ischemia. In this study, we examined astrocytic swelling/volume recovery in mice with TRPV4 and/or AQP4 deletion in response to in vitro ischemic conditions, to determine how the deletion of these channels can affect the development of cerebral edema. METHODS: We used three models of ischemia-related pathological conditions: hypoosmotic stress, hyperkalemia, and oxygenglucose deprivation (OGD), and observed their effect on astrocyte volume changes in acute brain slices of Aqp4-/-, Trpv4-/- and double knockouts. In addition, we employed single-cell RT-qPCR to assess the effect of TRPV4 and AQP4 deletion on the expression of other ion channels and transporters involved in the homeostatic functioning of astrocytes. RESULTS: Quantification of astrocyte volume changes during OGD revealed that the deletion of AQP4 reduces astrocyte swelling, while simultaneous deletion of both AQP4 and TRPV4 leads to a disruption of astrocyte volume recovery during the subsequent washout. Of note, astrocyte exposure to hypoosmotic stress or hyperkalemia revealed no differences in astrocyte swelling in the absence of AQP4, TRPV4, or both channels. Moreover, under ischemia-mimicking conditions, we identified two distinct subpopulations of astrocytes with low and high volumetric responses (LRA and HRA), and their analyses revealed that mainly HRA are affected by the deletion of AQP4, TRPV4, or both channels. Furthermore, gene expression analysis revealed reduced expression of the ion transporters KCC1 and ClC2 as well as the receptors GABAB and NMDA in Trpv4-/- mice. The deletion of AQP4 instead caused reduced expression of the serine/cysteine peptidase inhibitor Serpina3n. DISCUSSION: Thus, we showed that in AQP4 or TRPV4 knockouts, not only the specific function of these channels is affected, but also the expression of other proteins, which may modulate the ischemic cascade and thus influence the final impact of ischemia.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24012763
003      
CZ-PrNML
005      
20240726151354.0
007      
ta
008      
240723e20240515sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fncel.2024.1393751 $2 doi
035    __
$a (PubMed)38818517
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Hermanova, Zuzana $u Department of Cellular Neurophysiology, Institute of Experimental Medicine CAS, Prague, Czechia $u Second Faculty of Medicine, Charles University, Prague, Czechia
245    14
$a The deletion of AQP4 and TRPV4 affects astrocyte swelling/volume recovery in response to ischemia-mimicking pathologies / $c Z. Hermanova, L. Valihrach, J. Kriska, M. Maheta, J. Tureckova, M. Kubista, M. Anderova
520    9_
$a INTRODUCTION: Astrocytic Transient receptor potential vanilloid 4 (TRPV4) channels, together with Aquaporin 4 (AQP4), are suspected to be the key players in cellular volume regulation, and therefore may affect the development and severity of cerebral edema during ischemia. In this study, we examined astrocytic swelling/volume recovery in mice with TRPV4 and/or AQP4 deletion in response to in vitro ischemic conditions, to determine how the deletion of these channels can affect the development of cerebral edema. METHODS: We used three models of ischemia-related pathological conditions: hypoosmotic stress, hyperkalemia, and oxygenglucose deprivation (OGD), and observed their effect on astrocyte volume changes in acute brain slices of Aqp4-/-, Trpv4-/- and double knockouts. In addition, we employed single-cell RT-qPCR to assess the effect of TRPV4 and AQP4 deletion on the expression of other ion channels and transporters involved in the homeostatic functioning of astrocytes. RESULTS: Quantification of astrocyte volume changes during OGD revealed that the deletion of AQP4 reduces astrocyte swelling, while simultaneous deletion of both AQP4 and TRPV4 leads to a disruption of astrocyte volume recovery during the subsequent washout. Of note, astrocyte exposure to hypoosmotic stress or hyperkalemia revealed no differences in astrocyte swelling in the absence of AQP4, TRPV4, or both channels. Moreover, under ischemia-mimicking conditions, we identified two distinct subpopulations of astrocytes with low and high volumetric responses (LRA and HRA), and their analyses revealed that mainly HRA are affected by the deletion of AQP4, TRPV4, or both channels. Furthermore, gene expression analysis revealed reduced expression of the ion transporters KCC1 and ClC2 as well as the receptors GABAB and NMDA in Trpv4-/- mice. The deletion of AQP4 instead caused reduced expression of the serine/cysteine peptidase inhibitor Serpina3n. DISCUSSION: Thus, we showed that in AQP4 or TRPV4 knockouts, not only the specific function of these channels is affected, but also the expression of other proteins, which may modulate the ischemic cascade and thus influence the final impact of ischemia.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Valihrach, Lukas $u Department of Cellular Neurophysiology, Institute of Experimental Medicine CAS, Prague, Czechia $u Laboratory of Gene Expression, Institute of Biotechnology CAS, Vestec, Czechia
700    1_
$a Kriska, Jan $u Department of Cellular Neurophysiology, Institute of Experimental Medicine CAS, Prague, Czechia
700    1_
$a Maheta, Mansi $u Laboratory of Gene Expression, Institute of Biotechnology CAS, Vestec, Czechia
700    1_
$a Tureckova, Jana $u Department of Cellular Neurophysiology, Institute of Experimental Medicine CAS, Prague, Czechia
700    1_
$a Kubista, Mikael $u Laboratory of Gene Expression, Institute of Biotechnology CAS, Vestec, Czechia
700    1_
$a Anderova, Miroslava $u Department of Cellular Neurophysiology, Institute of Experimental Medicine CAS, Prague, Czechia
773    0_
$w MED00163312 $t Frontiers in cellular neuroscience $x 1662-5102 $g Roč. 18 (20240515), s. 1393751
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38818517 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240723 $b ABA008
991    __
$a 20240726151347 $b ABA008
999    __
$a ok $b bmc $g 2125470 $s 1224626
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 18 $c - $d 1393751 $e 20240515 $i 1662-5102 $m Frontiers in cellular neuroscience $n Front Cell Neurosci $x MED00163312
LZP    __
$a Pubmed-20240723

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...